Eli Lilly and Co., Lilly Corporate Center, Indianapolis, 46285 (www.lilly.com) discovers, develops, manufactures and sells pharmaceutical products for humans and animals. For the quarter ended March 31, the company reported net income of $529.5 million, or 50 cents per diluted share, on revenue of $4.6 billion. That compares with $727.9 million, or 68 cents per diluted share, on $4.7 billion in revenue a year earlier. The company’s shares trade on the New York Stock Exchange under the ticker symbol LLY. Information for Proxy Corner was taken from Yahoo Finance and from the company’s proxy statement dated March 23, 2015. View full Proxy Corner feature.